SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-031374
Filing Date
2023-11-13
Accepted
2023-11-13 06:30:52
Documents
68
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20230930_10q.htm   iXBRL 10-Q 1486388
2 EXHIBIT 10.1 ex_593341.htm EX-10.1 60590
3 EXHIBIT 31.1 ex_592326.htm EX-31.1 8853
4 EXHIBIT 31.2 ex_592327.htm EX-31.2 8892
5 EXHIBIT 32.1 ex_592328.htm EX-32.1 4659
6 EXHIBIT 32.2 ex_592329.htm EX-32.2 4658
  Complete submission text file 0001437749-23-031374.txt   6171707

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA crvo-20230930.xsd EX-101.SCH 50414
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20230930_def.xml EX-101.DEF 365874
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20230930_lab.xml EX-101.LAB 284705
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20230930_pre.xml EX-101.PRE 392017
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crvo-20230930_cal.xml EX-101.CAL 26746
62 EXTRACTED XBRL INSTANCE DOCUMENT dffn20230930_10q_htm.xml XML 860295
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 231394879
SIC: 2834 Pharmaceutical Preparations